Lumicell is changing the landscape of cancer surgery with a hand-held imaging system that enables surgeons to identify any cancer cells left behind on the tumor cavity walls and take action in real-time to improve patient outcomes.
Lumicell is addressing the number one challenge in cancer surgery – the need to remove all cancer cells during the first surgery while preserving healthy tissue.
Lumicell Appoints Kelly Londy as Chief Executive Officer, Announces Additional Financing -- The Board of Directors of Lumicell, Inc., a leader in the field of image-guided cancer surgery, announced today the appointment of Kelly Londy as Chief Executive Officer and member of the Board of Directors. W. David Lee, Founder of Lumicell, has moved into the role of President and Chief Scientific Officer.
Lumicell Appoints Felix Geissler, M.D., Ph.D. as Chief Medical Officer -- Lumicell has announced the appointment of Felix Geissler, M.D., Ph.D. as Chief Medical Officer. As a central member of Lumicell’s senior executive team, he will drive the clinical direction of the company and will work closely with the R&D and marketing teams to develop the overall business strategy.
W. David Lee, CEO, Lumicell Inc., gives keynote speech at MassBio’s “The Convergence of Medical Devices & Drugs: The Future of Combination Products” event in Waltham, MA.